Steward Partners Investment Advisory’s AnaptysBio ANAB Stock Holding History

Steward Partners Investment Advisory’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.9K	Hold	43	–	–	﹤0.01%	4142
2026 Q1	$2.38K	Hold	43	–	–	﹤0.01%	4002
2025 Q4	$2.08K	Hold	43	–	–	﹤0.01%	3948
2025 Q3	$1.32K	Hold	43	–	–	﹤0.01%	4010
2025 Q2	$955	Buy	+43	New	+$900	﹤0.01%	3872
2024 Q2	–	Sell	-150	Closed	-$3.38K	–	3611
2024 Q1	$3.38K	Hold	150	–	–	﹤0.01%	3159
2023 Q4	$3.21K	Hold	150	–	–	﹤0.01%	3110
2023 Q3	$2.69K	Hold	150	–	–	﹤0.01%	3021
2023 Q2	$3.05K	Hold	150	–	–	﹤0.01%	2943
2023 Q1	$3.26K	Hold	150	–	–	﹤0.01%	2917
2022 Q4	$4.65K	Buy	+150	New	+$4.24K	﹤0.01%	2799

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Steward Partners Investment Advisory's ANAB Position: Q2 2026 in Review

Steward Partners Investment Advisory held its AnaptysBio (ANAB) position steady in Q2 2026 at 43 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

Steward Partners Investment Advisory first reported a position in ANAB in Q4 2022 and has held it in 11 quarters since. The position peaked at $4.65K in Q4 2022. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Steward Partners Investment Advisory held 43 shares of AnaptysBio worth $2.9K as of Q2 2026.
Steward Partners Investment Advisory left its AnaptysBio share count unchanged in Q2 2026.
AnaptysBio made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4142 holding.
Steward Partners Investment Advisory first reported a position in AnaptysBio in Q4 2022 and has held it in 11 quarters since.
Steward Partners Investment Advisory's AnaptysBio position peaked at $4.65K in Q4 2022.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.